Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Microarrays and epidemiology: ensuring the impact and accessibility of research findings.

Troester MA, Millikan RC, Perou CM.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):1-4. doi: 10.1158/1055-9965.EPI-08-0867. No abstract available.

2.

Epidemiology, cancer genetics and microarrays: making correct inferences, using appropriate designs.

Potter JD.

Trends Genet. 2003 Dec;19(12):690-5. Review. No abstract available.

PMID:
14642749
3.

Microarrays and epidemiology: not the beginning of the end but the end of the beginning...

Webb PM, Merritt MA, Boyle GM, Green AC.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):637-8. No abstract available.

4.

Microarrays--chances and challenges.

Pilarsky CP, Schmitt AO, Dahl E, Rosenthal A.

Curr Opin Mol Ther. 1999 Dec;1(6):727-36. Review.

PMID:
19629870
5.

Molecular basis of disease prevention.

Borisch B.

Pathobiology. 2009;76(2):53-4. doi: 10.1159/000201673. No abstract available.

PMID:
19367125
6.

Microarrays, markers of disease, and the myth of "nonhypothesis-driven" research.

Greenberg DA.

Ann Neurol. 2001 Dec;50(6):695. No abstract available.

PMID:
11761464
7.

[Genomic classification of diseases].

Orntoft TF.

Ugeskr Laeger. 2005 May 16;167(20):2164-7. Danish. No abstract available.

PMID:
15987074
8.

[Molecular classification of tumors].

Lai MD.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 Jul;35(4):349-53. Chinese. No abstract available.

PMID:
16924695
9.

MIAME guidelines.

Knudsen TB, Daston GP; Teratology Society.

Reprod Toxicol. 2005 Jan-Feb;19(3):263. No abstract available.

PMID:
15686863
10.

Genetics and genomics: gene expression microarrays.

Ballman KV.

Circulation. 2008 Oct 7;118(15):1593-7. doi: 10.1161/CIRCULATIONAHA.107.714600. Review. No abstract available.

11.

Commentary on microarray analysis for gynecologists and obstetricians.

Liu CM.

Am J Obstet Gynecol. 2007 Sep;197(3):330-1; author reply 331. No abstract available.

PMID:
17826449
12.

Generalizing genetical genomics: getting added value from environmental perturbation.

Li Y, Breitling R, Jansen RC.

Trends Genet. 2008 Oct;24(10):518-24. doi: 10.1016/j.tig.2008.08.001. Epub 2008 Sep 4. Review.

PMID:
18774198
13.

Cancer comes under scrutiny in fresh genomics initiative.

Knight J.

Nature. 2001 Apr 19;410(6831):855. No abstract available.

PMID:
11309574
14.

Making the most of microarrays.

[No authors listed]

Nat Biotechnol. 2006 Sep;24(9):1039. No abstract available.

PMID:
16964193
15.

Empowering microarrays in the regulatory setting.

Casciano DA, Woodcock J.

Nat Biotechnol. 2006 Sep;24(9):1103. No abstract available.

PMID:
16964221
16.

Oligonucleotide microarray technology and its application to Mycobacterium avium subsp. paratuberculosis research: a review.

Pribylova R, Kralik P, Pavlik I.

Mol Biotechnol. 2009 May;42(1):30-40. doi: 10.1007/s12033-008-9137-5. Epub 2009 Jan 6. Review.

PMID:
19130317
17.

Molecular epidemiology and its current clinical use in cancer management.

Hartman M, Loy EY, Ku CS, Chia KS.

Lancet Oncol. 2010 Apr;11(4):383-90. doi: 10.1016/S1470-2045(10)70005-X. Review.

PMID:
20359664
18.

The promise of molecular profiling for cancer identification and treatment.

Cross D, Burmester JK.

Clin Med Res. 2004 Aug;2(3):147-50. Review. No abstract available.

19.

Consortia, 'big science' part of a paradigm shift for genetic epidemiology.

Kreeger K.

J Natl Cancer Inst. 2003 May 7;95(9):640-1. No abstract available.

PMID:
12734309
20.

Genes versus cancer.

Lewis R.

Nature. 2007 Apr 12;446(7137):826-7. No abstract available.

PMID:
17460827

Supplemental Content

Support Center